Factors associated with COVID-19 vaccine response in transplant recipients: a systematic review and meta-analysis
J Li, I Ayada, Y Wang, CM den Hoed, N Kamar… - …, 2022 - journals.lww.com
Background. The rapid development and universal access to vaccines represent a
milestone in combating the coronavirus disease 2019 (COVID-19) pandemic. However …
milestone in combating the coronavirus disease 2019 (COVID-19) pandemic. However …
COVID-19 and solid organ transplantation: Finding the right balance
R Opsomer, D Kuypers - Transplantation Reviews, 2022 - Elsevier
Background The COVID-19 pandemic has a great impact on solid organ transplant (SOT)
recipients due to their comorbidities and their maintenance immunosuppression. So far …
recipients due to their comorbidities and their maintenance immunosuppression. So far …
Decline in antibody concentration 6 months after two doses of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients and healthy controls
SR Hamm, DL Møller, L Pérez-Alós… - Frontiers in …, 2022 - frontiersin.org
Background Previous studies have indicated inferior responses to severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) …
syndrome coronavirus-2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) …
[HTML][HTML] The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls
Clinical outcomes in solid organ transplant (SOT) recipients with breakthrough COVID
(BTCo) after two doses of mRNA vaccination compared to the non-immunocompromised …
(BTCo) after two doses of mRNA vaccination compared to the non-immunocompromised …
Molnupiravir when used alone seems to be safe and effective as outpatient COVID-19 therapy for hemodialyzed patients and kidney transplant recipients
P Poznański, H Augustyniak-Bartosik, A Magiera-Żak… - Viruses, 2022 - mdpi.com
Background: Molnupiravir demonstrated an in vitro antiviral activity against positive-sense
RNA viruses, including SARS-CoV-2. The study aimed to present the results of outpatient …
RNA viruses, including SARS-CoV-2. The study aimed to present the results of outpatient …
Immunity after COVID-19 recovery and vaccination: similarities and differences
D Kamińska, D Dęborska-Materkowska… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is associated with a robust immune response. The …
syndrome coronavirus 2 (SARS-CoV-2), is associated with a robust immune response. The …
Susceptibility to SARS-CoV-2 infection and immune responses to COVID-19 vaccination among recipients of solid organ transplants
V Subramanian - The Journal of Infectious Diseases, 2023 - academic.oup.com
Solid organ transplant recipients (SOTRs) are at high risk for infections including SARS-CoV-
2, primarily due to use of immunosuppressive therapies that prevent organ rejection …
2, primarily due to use of immunosuppressive therapies that prevent organ rejection …
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
D Kamińska, H Augustyniak-Bartosik… - Journal of clinical …, 2021 - mdpi.com
Background. It is still unclear whether COVID-19 convalescent kidney transplant recipients
(KTR) and hemodialysis (HD) patients can develop anti-SARS-CoV-2 adaptive immunity …
(KTR) and hemodialysis (HD) patients can develop anti-SARS-CoV-2 adaptive immunity …
Absence of mortality differences between the first and second COVID-19 waves in kidney transplant recipients
B Berger, M Hazzan, N Kamar, H Francois… - Kidney International …, 2022 - Elsevier
Introduction SARS-CoV-2 pandemic evolved in 2 consecutive waves during 2020.
Improvements in the management of COVID-19 led to a reduction in mortality rates among …
Improvements in the management of COVID-19 led to a reduction in mortality rates among …
Reinfection with SARS‐CoV‐2 in solid‐organ transplant recipients: Incidence density and convalescent immunity prior to reinfection
S Morris, S Anjan, S Pallikkuth… - Transplant Infectious …, 2022 - Wiley Online Library
Background Long‐term protective immunity to severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) remains poorly characterized, particularly in solid organ …
coronavirus 2 (SARS‐CoV‐2) remains poorly characterized, particularly in solid organ …